|
Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection |
Pina JM, Clotet L, Ferrer A, Sala MR, Garrido P, Salleras L, Dominguez A |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Pina JM, Clotet L, Ferrer A, Sala MR, Garrido P, Salleras L, Dominguez A. Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection. Respiratory Medicine 2013; 107(5): 768-777 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Antitubercular Agents /administration & Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs /statistics & Drug-Induced Liver Injury /etiology; Female; Health Care Costs /statistics & Humans; Isoniazid /administration & Latent Tuberculosis /drug therapy /economics; Male; Middle Aged; Rifampin /administration & Sensitivity and Specificity; Spain; Treatment Outcome; Tuberculin Test; Young Adult; dosage /adverse effects /economics /therapeutic use; dosage /adverse effects /economics /therapeutic use; dosage /adverse effects /economics /therapeutic use; numerical data; numerical data AccessionNumber 22013017583 Date bibliographic record published 17/06/2013 |
|
|
|